Prothena Corp Files 8-K: Other Events & Financials
Ticker: PRTA · Form: 8-K · Filed: Aug 27, 2025 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | 8-K |
| Filed Date | Aug 27, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory-update
TL;DR
Prothena filed an 8-K today covering other events and financials.
AI Summary
On August 27, 2025, Prothena Corporation plc filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific monetary figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing signals to investors that Prothena Corporation has made a regulatory disclosure, potentially containing important updates on its business operations or financial health.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a change in risk.
Key Players & Entities
- PROTHENA CORP PUBLIC LTD CO (company) — Registrant
- August 27, 2025 (date) — Date of earliest event reported
- Ireland (jurisdiction) — State or other jurisdiction of incorporation
- 77 Sir John Rogerson’s Quay (address) — Business and mailing address
FAQ
What specific "Other Events" are being reported by Prothena Corporation?
The provided excerpt does not detail the specific "Other Events" being reported; it only lists the category of the filing.
What is the significance of filing "Financial Statements and Exhibits" in this 8-K?
Filing "Financial Statements and Exhibits" typically means the company is providing updated financial information or accompanying documents relevant to the reported events.
When was Prothena Corporation incorporated, and where is it headquartered?
Prothena Corporation is incorporated in Ireland and its headquarters are located at 77 Sir John Rogerson’s Quay, Grand Canal Docklands, Dublin 2, D02 VK60.
What is Prothena Corporation's standard industrial classification?
Prothena Corporation's standard industrial classification is "PHARMACEUTICAL PREPARATIONS [2834]".
Has Prothena Corporation undergone any previous name changes?
Yes, Prothena Corporation was formerly known as Prothena Corp plc until November 2, 2012, and prior to that, as Neotope Corp Ltd until September 26, 2012.
Filing Stats: 451 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-08-27 16:15:38
Key Financial Figures
- $0.01 — registered Ordinary Shares, par value $0.01 per share PRTA The Nasdaq Global Se
Filing Documents
- d38911d8k.htm (8-K) — 25KB
- d38911dex991.htm (EX-99.1) — 40KB
- g38911g0827023208674.jpg (GRAPHIC) — 4KB
- 0001193125-25-189765.txt ( ) — 192KB
- prta-20250827.xsd (EX-101.SCH) — 3KB
- prta-20250827_lab.xml (EX-101.LAB) — 18KB
- prta-20250827_pre.xml (EX-101.PRE) — 11KB
- d38911d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release dated August 27, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROTHENA CORPORATION PLC Dated: August 27, 2025 By: /s/ Tran B. Nguyen Name: Tran B. Nguyen Title: Chief Strategy Officer and Chief Financial Officer